Table 4.
Negative Predictive Value | Positive Predictive Value | |||
---|---|---|---|---|
Model | 17% prevalence | 32% prevalence | 17% prevalence | 32% prevalence |
Baseline (age + sex + APOE) | 0.915 (0.911, 0.919) | 0.824 (0.817, 0.832) | 0.301 (0.288, 0.315) | 0.495 (0.476, 0.516) |
PRS | 0.928 (0.925, 0.932) | 0.849 (0.842, 0.856) | 0.353 (0.338, 0.370) | 0.557 (0.535, 0.578) |
XGBoost | 0.928 (0.925, 0.932) | 0.849 (0.842, 0.855) | 0.357 (0.341, 0.374) | 0.563 (0.543, 0.584) |
NODEnn | 0.910 (0.906, 0.914) | 0.815 (0.807, 0.823) | 0.266 (0.254, 0.278) | 0.446 (0.429, 0.465) |
PRS + XBGoost | 0.935 (0.932, 0.939) | 0.863 (0.856, 0.869) | 0.386 (0.369, 0.403) | 0.593 (0.572, 0.615) |
XGBoost + NODEnn | 0.927 (0.923, 0.930) | 0.847 (0.839, 0.854) | 0.358 (0.342, 0.376) | 0.565 (0.544, 0.586) |
PRS + NODEnn | 0.932 (0.929, 0.936) | 0.857 (0.850, 0.864) | 0.342 (0.327, 0.359) | 0.539 (0.519, 0.559) |
PRS + XGBoost + NODEnn | 0.935 (0.932, 0.939) | 0.863 (0.856, 0.869) | 0.386 (0.370, 0.405) | 0.594 (0.574, 0.616) |